Selected research
Industry Research
Exosome CRO Industry Research Report 2026
Market perspective
The global Exosome CRO market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Exosome CRO market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Exosome CRO market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Exosome CRO market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Exosome CRO include MarinBio, Creative Biolabs, Bio-Connect, Frontage Laboratories, REPROCELL, Tamirna, Histocell, RoosterBio,Inc and Sino Biological Inc. and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Exosome CRO market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Exosome CRO.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Exosome CRO Market by Company
MarinBio
Creative Biolabs
Bio-Connect
Frontage Laboratories
REPROCELL
Tamirna
Histocell
RoosterBio,Inc
Sino Biological Inc.
AGC Biologics
Exosome CRO Segment by Type
Preclinical CRO
Clinical CRO
Exosome CRO Segment by Application
Laboratory
Universities
Bio Industry
Medical Industry
Exosome CRO Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exosome CRO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Exosome CRO and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exosome CRO.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Exosome CRO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Preclinical CRO
- Clinical CRO
Applications
- Laboratory
- Universities
- Bio Industry
- Medical Industry
Companies covered
- MarinBio
- Creative Biolabs
- Bio-Connect
- Frontage Laboratories
- REPROCELL
- Tamirna
- Histocell
- RoosterBio,Inc
- Sino Biological Inc.
- AGC Biologics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Exosome CRO by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Preclinical CRO
- 2.2.3 Clinical CRO
- 2.3 Exosome CRO by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Laboratory
- 2.3.3 Universities
- 2.3.4 Bio Industry
- 2.3.5 Medical Industry
- 2.4 Assumptions and Limitations
3 Exosome CRO Breakdown Data by Type
- 3.1 Global Exosome CRO Historic Market Size by Type (2021-2026)
- 3.2 Global Exosome CRO Forecasted Market Size by Type (2027-2032)
4 Exosome CRO Breakdown Data by Application
- 4.1 Global Exosome CRO Historic Market Size by Application (2021-2026)
- 4.2 Global Exosome CRO Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Exosome CRO Market Perspective (2021-2032)
- 5.2 Global Exosome CRO Growth Trends by Region
- 5.2.1 Global Exosome CRO Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Exosome CRO Historic Market Size by Region (2021-2026)
- 5.2.3 Exosome CRO Forecasted Market Size by Region (2027-2032)
- 5.3 Exosome CRO Market Dynamics
- 5.3.1 Exosome CRO Industry Trends
- 5.3.2 Exosome CRO Market Drivers
- 5.3.3 Exosome CRO Market Challenges
- 5.3.4 Exosome CRO Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Exosome CRO Players by Revenue
- 6.1.1 Global Top Exosome CRO Players by Revenue (2021-2026)
- 6.1.2 Global Exosome CRO Revenue Market Share by Players (2021-2026)
- 6.2 Global Exosome CRO Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Exosome CRO Head Office and Area Served
- 6.4 Global Exosome CRO Players, Product Type & Application
- 6.5 Global Exosome CRO Manufacturers Established Date
- 6.6 Global Exosome CRO Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Exosome CRO Market Size (2021-2032)
- 7.2 North America Exosome CRO Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Exosome CRO Market Size by Country (2021-2026)
- 7.4 North America Exosome CRO Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Exosome CRO Market Size (2021-2032)
- 8.2 Europe Exosome CRO Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Exosome CRO Market Size by Country (2021-2026)
- 8.4 Europe Exosome CRO Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Exosome CRO Market Size (2021-2032)
- 9.2 Asia-Pacific Exosome CRO Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Exosome CRO Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Exosome CRO Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Exosome CRO Market Size (2021-2032)
- 10.2 South America Exosome CRO Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Exosome CRO Market Size by Country (2021-2026)
- 10.4 South America Exosome CRO Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Exosome CRO Market Size (2021-2032)
- 11.2 Middle East & Africa Exosome CRO Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Exosome CRO Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Exosome CRO Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 MarinBio
- 12.1.1 MarinBio Company Information
- 12.1.2 MarinBio Business Overview
- 12.1.3 MarinBio Revenue in Exosome CRO Business (2021-2026)
- 12.1.4 MarinBio Exosome CRO Product Portfolio
- 12.1.5 MarinBio Recent Developments
- 12.2 Creative Biolabs
- 12.2.1 Creative Biolabs Company Information
- 12.2.2 Creative Biolabs Business Overview
- 12.2.3 Creative Biolabs Revenue in Exosome CRO Business (2021-2026)
- 12.2.4 Creative Biolabs Exosome CRO Product Portfolio
- 12.2.5 Creative Biolabs Recent Developments
- 12.3 Bio-Connect
- 12.3.1 Bio-Connect Company Information
- 12.3.2 Bio-Connect Business Overview
- 12.3.3 Bio-Connect Revenue in Exosome CRO Business (2021-2026)
- 12.3.4 Bio-Connect Exosome CRO Product Portfolio
- 12.3.5 Bio-Connect Recent Developments
- 12.4 Frontage Laboratories
- 12.4.1 Frontage Laboratories Company Information
- 12.4.2 Frontage Laboratories Business Overview
- 12.4.3 Frontage Laboratories Revenue in Exosome CRO Business (2021-2026)
- 12.4.4 Frontage Laboratories Exosome CRO Product Portfolio
- 12.4.5 Frontage Laboratories Recent Developments
- 12.5 REPROCELL
- 12.5.1 REPROCELL Company Information
- 12.5.2 REPROCELL Business Overview
- 12.5.3 REPROCELL Revenue in Exosome CRO Business (2021-2026)
- 12.5.4 REPROCELL Exosome CRO Product Portfolio
- 12.5.5 REPROCELL Recent Developments
- 12.6 Tamirna
- 12.6.1 Tamirna Company Information
- 12.6.2 Tamirna Business Overview
- 12.6.3 Tamirna Revenue in Exosome CRO Business (2021-2026)
- 12.6.4 Tamirna Exosome CRO Product Portfolio
- 12.6.5 Tamirna Recent Developments
- 12.7 Histocell
- 12.7.1 Histocell Company Information
- 12.7.2 Histocell Business Overview
- 12.7.3 Histocell Revenue in Exosome CRO Business (2021-2026)
- 12.7.4 Histocell Exosome CRO Product Portfolio
- 12.7.5 Histocell Recent Developments
- 12.8 RoosterBio,Inc
- 12.8.1 RoosterBio,Inc Company Information
- 12.8.2 RoosterBio,Inc Business Overview
- 12.8.3 RoosterBio,Inc Revenue in Exosome CRO Business (2021-2026)
- 12.8.4 RoosterBio,Inc Exosome CRO Product Portfolio
- 12.8.5 RoosterBio,Inc Recent Developments
- 12.9 Sino Biological Inc.
- 12.9.1 Sino Biological Inc. Company Information
- 12.9.2 Sino Biological Inc. Business Overview
- 12.9.3 Sino Biological Inc. Revenue in Exosome CRO Business (2021-2026)
- 12.9.4 Sino Biological Inc. Exosome CRO Product Portfolio
- 12.9.5 Sino Biological Inc. Recent Developments
- 12.10 AGC Biologics
- 12.10.1 AGC Biologics Company Information
- 12.10.2 AGC Biologics Business Overview
- 12.10.3 AGC Biologics Revenue in Exosome CRO Business (2021-2026)
- 12.10.4 AGC Biologics Exosome CRO Product Portfolio
- 12.10.5 AGC Biologics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst